TOP TIERMARKET NEWSWIRE
News & sentiment

ALTIMMUNE INC (ALT) — News & AI sentiment

ALTIMMUNE INC (ALT) news roundup. 2 stories in the last 24 hours, 2 in the past week, 4 over 30 days. Average 24-hour sentiment is 49/100 — neutral (50 is neutral). Recent insider activity (SEC Form 4, 90-day window): 1 purchases totalling $44K and 0 sales totalling $0 — net buying of $44K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
2
avg sentiment 49/100
7d stories
2
avg sentiment 49/100
30d stories
4
avg sentiment 55/100
Insider net (90d)
$44K
1 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

ALT news in the last 24 hours, 7 days, 30 days and 90 days

How much ALT coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowALT storiesAvg AI sentimentRead
Last 24 hours249/100ALT headlines →
Last 7 days249/100ALT headlines →
Last 30 days455/100ALT headlines →
Last 90 days2760.3/100ALT headlines →

Latest stories on ALT

5h ago
5h ago
Sep 8
Sep 3
Altimmune: Pemvidutide Performs, But A Long Wait Ahead
Seeking Alpha63 · neutralproduct/pr
Aug 13
Aug 12
Aug 12
Altimmune Q2 Earnings Call Highlights
Yahoo Finance56 · neutralearnings
Aug 12
Altimmune GAAP EPS of -$0.12 beats by $0.02
Seeking Alpha56 · neutralearnings
Aug 12
Altimmune, Inc. (ALT) files 8-K
SEC 8-K50 · neutralgeneral
Aug 12
Aug 12
Aug 12
Altimmune Q2 2026 Earnings Preview
Seeking Alpha50 · neutralearnings
Aug 11
Aug 5
Aug 3
Jul 28
Jul 28
Jul 28
Jul 28
Jul 28
Altimmune Reports Positive Phase 2 Data in AUD
TipRanks67 · bullishproduct/pr
Jul 28
Jul 28
Altimmune stock surges 18% on positive trial results
Investing.com Markets73 · bullishproduct/pr
Jul 28
Altimmune, Inc. (ALT) files 8-K
SEC 8-K50 · neutralgeneral
Jul 28
Jul 28
Open ALT in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →